Steroids' Neuroprotective Potential in Severe Cerebral Venous Thrombosis: Experimental and Clinical Exploration of NLRP3 Inflammasome Inhibition

Shuyuan Hu,Yaqin Gu,Limin Hou,Jia Liu,Haiping Zhao,Yumin Luo,Chunxiu Wang,Xunming Ji,Guiyou Liu,Jiangang Duan
DOI: https://doi.org/10.1111/cns.70125
2024-11-27
CNS Neuroscience & Therapeutics
Abstract:The NLRP3 inflammasome exhibited a strong correlation with neurological injury in severe CVT, both in rats and patients. The neuroprotective benefits of steroid treatment in severe CVT‐associated brain injury were possibly attributed to its ability to suppress NLRP3 inflammasome‐induced inflammation. Background NLRP3 inflammasome‐related inflammation might play an important role in the pathophysiology of severe CVT. The use of steroids as anti‐inflammatory agents in improving severe CVT prognosis remains controversial. Methods A total of 94 male Sprague–Dawley rats were used. We evaluated the dynamic and association between NLRP3 inflammasome in brain, blood, and CSF and severity in severe CVT rats and/or patients. We also explored the effect of steroids on NLRP3 activation, neurological injury, and CSF circulation disturbance after CVT in animals and/or patients. Results In rats, compared with the sham group, NLRP3‐related factors rose on day 1, peaked on day 2 (NLRP3, Sham: 0.79 ± 0.22; day 2: 1.25 ± 0.08, p
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?